Concepedia
Statistics
Publications
7
Citations
161
H-Index
Active since
2002
Affiliations
AbbVie (United States)(Current)
University of Massachusetts Chan Medical School
Abbott (United States)
Inventiva (France)
Craig Wallace is an author at AbbVie (United States) specializing in immunology, life sciences, and pharmacology.
Publications per year
2002–2020
The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity
Philip D. Bardwell, Jijie Gu, Donna McCarthy et al. · The Journal of Immunology · 2009 · 69 citations
Life Sciences, Immunology, Pharmacology +17
A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection
Wendy Waegell, M Babineau, Michelle Hart et al. · Transplantation Proceedings · 2002 · 25 citations
Life Sciences, Immunology, Molecular Biology +11
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
Jérôme Amaudrut, M.A. Argiriadi, Martine Barth et al. · Bioorganic & Medicinal Chemistry Letters · 2019 · 18 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +11
Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases
Bradford L. McRae, Craig Wallace, Kathleen Fitzgerald Dixon et al. · International Immunopharmacology · 2004 · 14 citations
Life Sciences, Immunology, Molecular Biology +16
Inhibition of Interleukin-23–Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt
Stephen B. Gauld, Sébastien Jacquet, Donna M. Gauvin et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 14 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
1–5 of 7